Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Prospective Study to Evaluate the Incrediwear Products Immediately After ACL or ACL+MCL Arthroscopic Surgery

NCT06240780 is registered in ClinicalTrials.gov with Oklahoma Joint Reconstruction Institute as lead sponsor.

NCT NCT06240780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06240780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Prospective Study to Evaluate the Incrediwear Products Immediately After ACL or ACL+MCL Arthroscopic Surgery
Lead sponsor
Oklahoma Joint Reconstruction Institute
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
August 30, 2024
Completion date
December 31, 2026
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior cruciate ligament reconstruction, arthroscopic surgical procedures